Wednesday, August 1, 2007
Fusarium
Currently, the available information on human health effects associated with fumonisins is not conclusive. However, based on the wealth of available information on the adverse animal health effects associated with fumonisins (discussed in this document and in the document entitled "Background Paper in Support of Fumonisin Levels in Animal Feed" prepared by FDA's CVM), FDA believes that human health risks associated with fumonisins are possible.
Based on the current available occurrence data, levels of fumonisins in human foods derived from corn are normally quite low. At the present time, FDA believes that these levels present a negligible public health risk. Nevertheless, FDA considers the fumonisin guidance levels to be a prudent public health measure during the development of a better understanding of the human health risk associated with fumonisins and the development of a long-term risk management policy and program by the agency for the control of fumonisins in human foods and animal feeds.
The recommended maximum levels for fumonisins in corn and corn products intended for human consumption (Table 1) are based on concerns associated with hazards shown primarily by animal studies. However, based on available information on the occurrence of fumonisins, FDA believes that typical fumonisin levels found in corn and corn products intended for human consumption are much lower than the recommended levels.
Total Fumonisins(FB1 + FB2 + FB3) parts per million (ppm)
Product:
1) Degermed dry milled corn products (e.g., flaking grits, corn grits, corn meal, corn flour with fat content of <>2.25 %, dry weight basis)
(4 ppm)
3) Dry milled corn bran
(4 ppm)
4) Cleaned corn intended for masa production (
4 ppm)
5) Cleaned corn intended for popcorn
(3 ppm)
http://www.cfsan.fda.gov/~dms/fumonbg3.html
Currently, the available information on human health effects associated with fumonisins is not conclusive. However, based on the wealth of available information on the adverse animal health effects associated with fumonisins (discussed in this document and in the document entitled "Background Paper in Support of Fumonisin Levels in Animal Feed" prepared by FDA's CVM), FDA believes that human health risks associated with fumonisins are possible.
Based on the current available occurrence data, levels of fumonisins in human foods derived from corn are normally quite low. At the present time, FDA believes that these levels present a negligible public health risk. Nevertheless, FDA considers the fumonisin guidance levels to be a prudent public health measure during the development of a better understanding of the human health risk associated with fumonisins and the development of a long-term risk management policy and program by the agency for the control of fumonisins in human foods and animal feeds.
The recommended maximum levels for fumonisins in corn and corn products intended for human consumption (Table 1) are based on concerns associated with hazards shown primarily by animal studies. However, based on available information on the occurrence of fumonisins, FDA believes that typical fumonisin levels found in corn and corn products intended for human consumption are much lower than the recommended levels.
Total Fumonisins(FB1 + FB2 + FB3) parts per million (ppm)
Product:
1) Degermed dry milled corn products (e.g., flaking grits, corn grits, corn meal, corn flour with fat content of <>2.25 %, dry weight basis)
(4 ppm)
3) Dry milled corn bran
(4 ppm)
4) Cleaned corn intended for masa production (
4 ppm)
5) Cleaned corn intended for popcorn
(3 ppm)
http://www.cfsan.fda.gov/~dms/fumonbg3.html
6:58 PM
i love spongebob and patrick!